Valone, F H <br/><br/>
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.  [electronic resource] 

 -  Journal of immunotherapy : official journal of the Society for Biological Therapy  Jun 1991 
 - 207-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1053-8550 
<br/><br/><label>Standard No.: </label>10.1097/00002371-199106000-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Female<br/>Fluorouracil--administration & dosage<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Survival Rate